| Shawn T Butela, MD | |
|
110 Kingsley Ln, Suite 305, Norfolk, VA 23505-4614 | |
| (757) 889-5942 | |
| (757) 889-5422 |
| Full Name | Shawn T Butela |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 29 Years |
| Location | 110 Kingsley Ln, Norfolk, Virginia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891734372 | NPI | - | NPPES |
| 00A711430 | Medicaid | CA | |
| 00A711430 | Other | CA | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | A71143 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Sentara Obici Hospital | Suffolk, VA | Hospital |
| Sentara Princess Anne Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hampton Roads Radiology Associates, Pc | 4880688506 | 39 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced the initiation of patient enrollment in a Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb in healthy volunteers.
Today Virginia became the first state in the nation to enact legislation to protect their citizens from being forced to purchase health insurance or participate in any health care system against their will. The American Legislative Exchange Council (ALEC) has identified 37 other states that have similar bills pending or have announced that they will introduce this legislation. Already, at least one house of the legislatures in Idaho, Missouri, and Tennessee have also passed such legislation.
A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival - by more than a year - in some women with advanced ovarian cancer. Results from a seven-year study of more than 400 patients nationwide are published in the New England Journal of Medicine.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Promethazine Hydrochloride (HCl) Tablets USP, 12.5 mg, 25 mg and 50 mg. Promethazine HCl Tablets are used to relieve the symptoms of certain allergic reactions, such as perennial and seasonal allergic rhinitis.
› Verified 7 days ago
| Entity Name | Hampton Roads Radiology Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174533624 PECOS PAC ID: 4880688506 Enrollment ID: O20041123000788 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced the initiation of patient enrollment in a Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb in healthy volunteers.
Today Virginia became the first state in the nation to enact legislation to protect their citizens from being forced to purchase health insurance or participate in any health care system against their will. The American Legislative Exchange Council (ALEC) has identified 37 other states that have similar bills pending or have announced that they will introduce this legislation. Already, at least one house of the legislatures in Idaho, Missouri, and Tennessee have also passed such legislation.
A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival - by more than a year - in some women with advanced ovarian cancer. Results from a seven-year study of more than 400 patients nationwide are published in the New England Journal of Medicine.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Promethazine Hydrochloride (HCl) Tablets USP, 12.5 mg, 25 mg and 50 mg. Promethazine HCl Tablets are used to relieve the symptoms of certain allergic reactions, such as perennial and seasonal allergic rhinitis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shawn T Butela, MD 110 Kingsley Ln, Suite 305, Norfolk, VA 23505-4614 Ph: (757) 889-5942 | Shawn T Butela, MD 110 Kingsley Ln, Suite 305, Norfolk, VA 23505-4614 Ph: (757) 889-5942 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced the initiation of patient enrollment in a Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb in healthy volunteers.
Today Virginia became the first state in the nation to enact legislation to protect their citizens from being forced to purchase health insurance or participate in any health care system against their will. The American Legislative Exchange Council (ALEC) has identified 37 other states that have similar bills pending or have announced that they will introduce this legislation. Already, at least one house of the legislatures in Idaho, Missouri, and Tennessee have also passed such legislation.
A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival - by more than a year - in some women with advanced ovarian cancer. Results from a seven-year study of more than 400 patients nationwide are published in the New England Journal of Medicine.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Promethazine Hydrochloride (HCl) Tablets USP, 12.5 mg, 25 mg and 50 mg. Promethazine HCl Tablets are used to relieve the symptoms of certain allergic reactions, such as perennial and seasonal allergic rhinitis.
› Verified 7 days ago
Dr. Kevin Halista, M.D. Radiology Medicare: May Accept Medicare Assignments Practice Location: 110 Kingsley Ln, Suite 305, Norfolk, VA 23505 Phone: 804-262-6900 | |
Dr. Julie Anne Krumreich, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 218 E 42nd St, Norfolk, VA 23504 Phone: 757-963-6713 | |
Norbertina L Banson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 835 Glenrock Rd, Ste 100a, Norfolk, VA 23502 Phone: 757-252-3370 Fax: 757-252-3225 | |
Mark Cockerill, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 150 Kingsley Ln, Norfolk, VA 23505 Phone: 757-889-5422 Fax: 757-889-5450 | |
Dr. Marc L Pessar, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 850 Kempsville Rd, Norfolk, VA 23502 Phone: 757-466-5910 Fax: 757-466-5748 | |
Dr. Suraj Jaisinghani, MD Radiology Medicare: Medicare Enrolled Practice Location: 600 Gresham Dr, Norfolk, VA 23507 Phone: 585-922-2932 | |
Todd Matthew Berry, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 110 Kingsley Ln Ste 305, Norfolk, VA 23505 Phone: 757-889-5422 Fax: 757-889-5450 |